Drawn up syringes containing the AstraZeneca COVID-19 vaccines and the empty vial are seen in a tray at the Claremont Showgrounds Covid-19 Vaccination Clinic on May 03, 2021 in Perth, Australia.

AstraZeneca has agreed to pay up to $2 billion for an experimental pill used to treat obesity and type 2 diabetes—the latest pharmaceutical firm to bet on treatment similar to popular weight ...

AstraZeneca agreed to pay $1.1 billion for Icosavax to expand its reach into cutting-edge vaccine technology with Icosavax's innovative vaccine platform.

AstraZeneca Plc agreed to buy Icosavax Inc. for as much as $1.1 billion to gain a developer of innovative vaccines for respiratory viruses.

AstraZeneca Plc agreed to buy US biotech CinCor Pharma Inc. for as much as $1.8 billion to gain a promising new treatment for hypertension and kidney disease.. The deal is the first sizable one ...

AstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a plethora of new shots that has led to a decline in demand. The vaccine — called Vaxzevria and ...